Skip to content
Enroll in Research
Get News
Search
Search
Donate
Enroll in Research
Get News
Search
Search
Donate
Home
About
Dupuytren Disease and the Dupuytren Research Group
Vision, Mission, Values and Activities
Research Committee
Board of Directors
Staff and Support
Associations
Legal Documentation
Contact Us
For Patients
Patients
Dupuytren FAQs
Dupuytren Specialists
Enroll in the IDDB
Connect With Others
Dupuytren Advocacy
Patient Financial Support
For Professionals
Information for Scientists and Clinicians
DRG Literature Archives
Forms for Dupuytren Documentation
Request Dupuytren Research Group Patient Brochures
For Sponsors
Donate Page
Donor List
Information for Sponsors
Blog
Contact Us
Donate
Contact Us
Subscribe to eNewsletter
Request Brochures
Patient Financial Support
Donate
Donate
Dupuytren Advocacy
Donor List
Home
About
Dupuytren Disease and the Dupuytren Research Group
Vision, Mission, Values and Activities
Research Committee
Board of Directors
Staff and Support
Associations
Legal Documentation
Contact Us
For Patients
Patients
Dupuytren FAQs
Dupuytren Specialists
Enroll in the IDDB
Connect With Others
Dupuytren Advocacy
Patient Financial Support
For Professionals
Information for Scientists and Clinicians
DRG Literature Archives
Forms for Dupuytren Documentation
Request Dupuytren Research Group Patient Brochures
For Sponsors
Donate Page
Donor List
Information for Sponsors
Blog
Contact Us
Donate
Contact Us
Subscribe to eNewsletter
Request Brochures
Patient Financial Support
Donate
Donate
Dupuytren Advocacy
Donor List
Ending Dupuytren disease
December 20, 2018
4:48 pm
What must be done to end Dupuytren disease?
Share:
More Posts
Will This Stop My Dupuytren?
Research Update from the Dupuytren Research Group
Now Online: Brussels Dupuytren Presentations
Happy Thanksgiving from the Dupuytren Research Group!
Recent Dupuytren Publications
Delayed Manipulation after Collagenase Injection for Dupuytren Contracture: Two Case Reports and Consideration of Complications
Local Corticosteroid Injection in Hand Surgery: A Review of Molecular Mechanisms, Steroid Selection, and Clinical Outcomes
Trauma, surgery, and microtrauma as triggers for Dupuytren's disease: A systematic review
Performance of Large Language Models in Image-Based Evaluation of Dupuytren Contracture
Integrated bulk and single-cell transcriptomic analyses with experimental validation identify PLOD1 as a diagnostic biomarker and TGF-beta1-responsive profibrotic mediator in dupuytren's disease
Prev
Previous
PrecisionFDA Dupuytren Blog
Next
Happy Holidays from the Dupuytren Research Group
Next
Secret Link
